The role of IVIg in the treatment of patients with stiff person syndrome and other neurological diseases associated with anti-GAD antibodies

Journal of Neurology

Volumn 252, Issue SUPP.1, 2005, Pages

  Dalakas, Marinos C ^a  

^a NATIONAL INSTITUTES OF HEALTH   (United States)

Author keywords

Gad antibodies; Intravenous immunoglobulin; Muscle stiffness; Stiff person syndrome

Indexed keywords

EID: 77951615750     PISSN: 03405354     EISSN: 14321459     Source Type: Journal    
DOI: 10.1007/s00415-005-1105-4     Document Type: Conference Paper

References (24)

1. Ellis MT, Atkinson AM (1996) The clinical significance of an autoimmune response against glutamic acid decarboxylase. Nature Medicine 2:148-153
2. Daw K, Ujihara N, Atkinson M, Powers AC (1996) Glutamic acid decarboxylase autoantibodies in stiff-man syndrome and insulin-dependent diabetes mellitus exhibit similarities and differences in epitope recognition. J Immunol 156:818-825
3. Solimena M, Folli F, Aparisi R, Pozza G, De Camilli P (1990) Autoantibodies to GABA-ergic neurons and pancreatic beta cells in stiff-man syndrome. N Engl J Med 322:1555-1560
4. Dalakas MC, Fujii M, Li M, McElroy B (2000) The clinical spectrum of antiGAD antibody-positive patients with stiff-person syndrome. Neurology 55:1531-1535
5. Dalakas MC (1999) Autoantibodies and immunopathogenesis of the stiffperson syndrome. In: Levy LM moderator: The stiff-person syndrome: an autoimmune disorder affecting neurotransmission of gamma-aminobutyric acid. Ann Intern Med 131:522-530
6. Dalakas MC, Li M, Fujii M, Jacobowitz DM (2001) Stiff-person syndrome: quantification, specificity and intrathecal synthesis of GAD65 antibodies. Neurology 57:780-785
7. Murinson BB, Butler M, Marfurt K, Gleason S, De Camilli P, et al. (2004) Markedly elevated GAD antibodies in SPS: effects of age and illness duration. Neurology 63:2146-2148
8. Peltola J, Kulmala P, Isojarvi J, Saiz A, Latvala K, et al. (2000) Autoantibodies to glutamic acid decarboxylase in patients with therapy-resistant epilepsy. Neurology 55:46-50
9. Honnorat J, Saiz A, Giometto B, Vincent A, Brieva L, de Andres C, et al. (2001) Cerebellar ataxia with antiglutamic acid decarboxylase antibodies: study of 14 patients. Arch Neurol 58:225-230
10. Pearce DA, Atkinson M, Tagle DA (2004) Glutamic acid decarboxylase autoimmunity in Batten disease and other disorders. Neurology 63: 2001-2005
11. Vernino S, Lennon VA (2004) Autoantibody profiles and neurological correlations of Thymoma. Clin Cancer Res 10:7270-7275
12. Dalakas MC (1999) Therapeutic considerations of patients with stiff-person syndrome. In: Levy LM (moderator) The stiff-person syndrome: an autoimmune disorder affecting neurotransmission of-aminobutyric acid. Ann Intern Med 131:523-524
13. Vasconcelos OM, Dalakas MC (2003) Therapies for stiff person syndrome. Curr Treat Options Neurol 5:79-90
14. Barker RA, Revesz T, Thorn M, Marsden CD, Brown P (1998) Review of 23 patients affected by the stiff man syndrome: clinical subdivision into stiff trunk (man) syndrome, stiff limb syndrome, and progressive encephalomyelitis with rigidity. J Neurol Neurosurg Psychiatry 65:633-640
15. Dalakas MC, Fujii M, Li M, Lutfi B, Kyhos J, McElroy B (2001) High-dose intravenous immunoglobulin for stiffperson syndrome. N Engl J of Med 345:1870-1876
16. Meinck HM, Ricker K, Hulser PJ, SolimenaM (1995) Stiff man syndrome: neurophysiological findings in eight patients. J Neurol. 242:134-142
17. Dinkel K MH, Jury KM, et al. (1998) Inhibition of gama-aminoutric acid, synthesis by glutamic acid, decarboxylase autoantibodies in stiff-man syndrome. Ann Neurol. 44:194-201
18. Ishida K, Mitoma H, Song Si-γ, et al. (1999) An elective suppression of cerebellar GABAergic transmission by an autoantibody to glutamic acid decarboxylase. Ann Neurol. 46:263-267
19. Amato AA, Cornman EW, Kissel JT (1994) Treatment of stiff-man syndrome with intravenous immunoglobulin. Neurology 44:1652-1654
20. Barker RA MC (1997) Successful treatment of stiff-man syndrome with intravenous immunoglobulin. J Neurol Neurosurg Psychiatry 62:426
21. Dalakas MC (2004) Intravenous immunoglobulin in autoimmune neuromuscular diseases. JAMA 291: 2367-2375
22. Dalakas MC (2004) The use of intravenous immunoglobulin in the treatment of autoimmune neurological disorders: Evidence-based indications and safety profile. Pharmacol. Therapeutics 102:177-193
23. Weinberger DR (2001) Anxiety at the frontier of molecular medicine. N Engl J Med 344:1247-1249
24. Rakocevic G, Raju R, Dalakas MC (2004) Anti-glutamic acid decarboxylase antibodies in the serum and cerebrospinal fluid of patients with stiffperson syndrome: correlation with clinical severity. Arch Neurol 61: 902-904